Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 11 | 2022 | 34 | 3.330 |
Why?
|
| Cannabis | 4 | 2023 | 85 | 2.700 |
Why?
|
| Marijuana Use | 5 | 2019 | 38 | 1.870 |
Why?
|
| Students | 5 | 2018 | 54 | 1.750 |
Why?
|
| Soft Tissue Infections | 4 | 2022 | 10 | 1.600 |
Why?
|
| Substance-Related Disorders | 4 | 2025 | 425 | 1.430 |
Why?
|
| Hallucinogens | 2 | 2022 | 23 | 1.390 |
Why?
|
| Skin Diseases, Infectious | 4 | 2021 | 5 | 1.360 |
Why?
|
| Motivation | 4 | 2023 | 115 | 1.190 |
Why?
|
| Marijuana Abuse | 5 | 2023 | 43 | 1.010 |
Why?
|
| Universities | 4 | 2018 | 15 | 0.940 |
Why?
|
| Electronic Nicotine Delivery Systems | 2 | 2023 | 29 | 0.910 |
Why?
|
| Humans | 30 | 2025 | 17314 | 0.820 |
Why?
|
| Mobile Applications | 1 | 2023 | 14 | 0.800 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 100 | 0.790 |
Why?
|
| Harm Reduction | 4 | 2025 | 4 | 0.780 |
Why?
|
| Ecological Momentary Assessment | 2 | 2023 | 4 | 0.770 |
Why?
|
| Bacterial Infections | 3 | 2012 | 9 | 0.770 |
Why?
|
| Young Adult | 11 | 2023 | 2465 | 0.750 |
Why?
|
| Adult | 18 | 2025 | 7500 | 0.740 |
Why?
|
| Marijuana Smoking | 4 | 2019 | 52 | 0.730 |
Why?
|
| Tobacco Products | 1 | 2021 | 14 | 0.720 |
Why?
|
| Tobacco Use Disorder | 1 | 2021 | 36 | 0.710 |
Why?
|
| Crisis Intervention | 1 | 2021 | 13 | 0.690 |
Why?
|
| Medical Marijuana | 1 | 2021 | 23 | 0.690 |
Why?
|
| Motivational Interviewing | 1 | 2021 | 34 | 0.680 |
Why?
|
| Craving | 2 | 2023 | 8 | 0.670 |
Why?
|
| Male | 18 | 2025 | 9804 | 0.660 |
Why?
|
| Chronic Pain | 1 | 2022 | 127 | 0.660 |
Why?
|
| Risk-Taking | 5 | 2022 | 106 | 0.650 |
Why?
|
| Alcoholism | 1 | 2023 | 337 | 0.650 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 224 | 0.650 |
Why?
|
| Behavior Therapy | 1 | 2021 | 126 | 0.630 |
Why?
|
| Stroke | 1 | 2022 | 309 | 0.610 |
Why?
|
| Colorado | 5 | 2018 | 164 | 0.590 |
Why?
|
| Vomiting | 4 | 2022 | 15 | 0.590 |
Why?
|
| Female | 17 | 2025 | 12396 | 0.580 |
Why?
|
| Injections | 1 | 2017 | 5 | 0.560 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2017 | 5 | 0.560 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 2 | 0.560 |
Why?
|
| Personality | 1 | 2017 | 9 | 0.560 |
Why?
|
| Social Environment | 1 | 2018 | 85 | 0.540 |
Why?
|
| Depression | 2 | 2019 | 486 | 0.510 |
Why?
|
| Anxiety | 1 | 2017 | 154 | 0.510 |
Why?
|
| Virus Diseases | 2 | 2012 | 4 | 0.490 |
Why?
|
| Adolescent | 8 | 2023 | 3538 | 0.490 |
Why?
|
| Achievement | 1 | 2015 | 3 | 0.470 |
Why?
|
| Risk Reduction Behavior | 2 | 2012 | 104 | 0.460 |
Why?
|
| Middle Aged | 9 | 2025 | 7836 | 0.460 |
Why?
|
| HIV Infections | 3 | 2022 | 712 | 0.440 |
Why?
|
| Needles | 2 | 2022 | 3 | 0.430 |
Why?
|
| Hygiene | 2 | 2022 | 4 | 0.420 |
Why?
|
| Program Development | 1 | 2012 | 63 | 0.380 |
Why?
|
| Skin Care | 1 | 2012 | 2 | 0.380 |
Why?
|
| Hepatitis C | 2 | 2010 | 65 | 0.370 |
Why?
|
| Mental Health | 2 | 2025 | 169 | 0.360 |
Why?
|
| Abscess | 1 | 2010 | 6 | 0.330 |
Why?
|
| Risk Factors | 6 | 2021 | 3258 | 0.320 |
Why?
|
| Drug Users | 2 | 2025 | 8 | 0.320 |
Why?
|
| Self Efficacy | 1 | 2008 | 68 | 0.280 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 1280 | 0.280 |
Why?
|
| Aged | 3 | 2023 | 6084 | 0.270 |
Why?
|
| Surveys and Questionnaires | 2 | 2010 | 1282 | 0.270 |
Why?
|
| Cohort Studies | 2 | 2023 | 2514 | 0.260 |
Why?
|
| Hawaii | 2 | 2023 | 58 | 0.240 |
Why?
|
| Wearable Electronic Devices | 1 | 2025 | 6 | 0.230 |
Why?
|
| Biosensing Techniques | 1 | 2025 | 4 | 0.230 |
Why?
|
| Peer Group | 1 | 2025 | 54 | 0.230 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 24 | 0.230 |
Why?
|
| Self Report | 2 | 2018 | 257 | 0.220 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1151 | 0.220 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2003 | 74 | 0.200 |
Why?
|
| Physical Fitness | 2 | 2019 | 70 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 245 | 0.190 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 197 | 0.180 |
Why?
|
| Tobacco Use | 1 | 2021 | 14 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 271 | 0.170 |
Why?
|
| Inpatients | 2 | 2019 | 79 | 0.170 |
Why?
|
| Cannabinoids | 2 | 2017 | 8 | 0.170 |
Why?
|
| Behavior Control | 1 | 2020 | 4 | 0.170 |
Why?
|
| Disinfection | 1 | 2020 | 2 | 0.170 |
Why?
|
| Skin | 1 | 2020 | 13 | 0.170 |
Why?
|
| Chronic Disease | 1 | 2022 | 397 | 0.160 |
Why?
|
| Inflammation | 1 | 2019 | 63 | 0.150 |
Why?
|
| Smoking | 1 | 2021 | 429 | 0.150 |
Why?
|
| Data Collection | 2 | 2014 | 238 | 0.150 |
Why?
|
| Health Behavior | 2 | 2012 | 346 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2023 | 704 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 381 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2019 | 134 | 0.140 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 12 | 0.140 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 18 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 293 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 603 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2014 | 108 | 0.120 |
Why?
|
| Text Messaging | 1 | 2014 | 34 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2017 | 1076 | 0.100 |
Why?
|
| Focus Groups | 1 | 2012 | 143 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 879 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 211 | 0.090 |
Why?
|
| Cocaine-Related Disorders | 1 | 2010 | 5 | 0.080 |
Why?
|
| Heroin Dependence | 1 | 2010 | 6 | 0.080 |
Why?
|
| United States | 3 | 2023 | 3866 | 0.080 |
Why?
|
| Hydrocortisone | 2 | 2019 | 18 | 0.080 |
Why?
|
| Health Surveys | 1 | 2010 | 245 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2010 | 306 | 0.080 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 58 | 0.080 |
Why?
|
| Risk | 1 | 2010 | 496 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 36 | 0.070 |
Why?
|
| Rhode Island | 1 | 2008 | 2 | 0.070 |
Why?
|
| Psychometrics | 1 | 2008 | 119 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 357 | 0.070 |
Why?
|
| Pennsylvania | 1 | 2025 | 26 | 0.060 |
Why?
|
| Prevalence | 1 | 2008 | 840 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2025 | 36 | 0.060 |
Why?
|
| Heart Rate | 1 | 2025 | 38 | 0.060 |
Why?
|
| New England | 1 | 2020 | 12 | 0.040 |
Why?
|
| Massachusetts | 1 | 2019 | 60 | 0.040 |
Why?
|
| Nerve Growth Factor | 1 | 2019 | 1 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 14 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 4 | 0.040 |
Why?
|
| Dronabinol | 1 | 2019 | 1 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2019 | 12 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 25 | 0.040 |
Why?
|
| Testosterone | 1 | 2019 | 22 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 70 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 45 | 0.040 |
Why?
|
| Self Care | 1 | 2019 | 144 | 0.040 |
Why?
|
| Biomarkers | 1 | 2019 | 307 | 0.040 |
Why?
|
| Nausea | 1 | 2017 | 7 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 28 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 55 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1266 | 0.030 |
Why?
|
| Mental Recall | 1 | 2014 | 29 | 0.030 |
Why?
|
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->